Fintech Doubters Being Proved Wrong: Index’ Mignot

We see the extraordinary valuations of generative AI enabling companies. Is that really where the activity still is. Is there room and oxygen in the room for others.I think that's where the majority of the activities we see, about two thirds of our deals are in the DNA space, but it also other big areas that are still very active. We still do a lot in healthcare. There's a lot in fintech.So it's not all jenn-air. The other thing is that Jenn-air is becoming everything. You know, they're talking about health ...